The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Benlysta 200 mg/mL autoinjectors. The contract, valued at $5,779.12, has an ultimate completion date of January 14, 2025. This award is associated with AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a prime contractor, AmerisourceBergen serves as a critical supplier of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and other healthcare products, to federal government agencies and military healthcare facilities.
Generated 3/21/25, 10:03 AM